{
  "docId": "019dd923-5efe-75c0-8dff-2e87a7b85930",
  "docSlug": "d74f6dfc5c764997",
  "documentTitle": "2026 Capital Markets Day AM",
  "authorId": "Syncona",
  "authorName": "Syncona",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 40,
  "pageCount": 55,
  "prevPage": 39,
  "nextPage": 41,
  "slideType": "industry_trends",
  "function": "quantify_impact",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a stacked area chart to visualize market growth, with specific CAGR metrics for different drug modalities.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "area_chart",
    "callout_box",
    "big_number",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5efe-75c0-8dff-2e87a7b85930/40",
  "deckHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930",
  "deckJsonHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930.json",
  "deckAnchorHref": "/decks/019dd923-5efe-75c0-8dff-2e87a7b85930#slide-40",
  "components": [
    {
      "bbox": {
        "h": 0.332,
        "w": 0.368,
        "x": 0.596,
        "y": 0.082
      },
      "kind": "callout",
      "text": "MARKET SHARE OF FIRST-IN-CLASS PRODUCTS MORE THAN DOUBLED",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a985747-d6bd-46d3-b0b3-c838d6d1aa33",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.95,
        "x": 0.03,
        "y": 0.38
      },
      "kind": "chart",
      "text": null,
      "attrs": null,
      "subkind": "area-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64f9cd58-791a-4497-ab3b-468c4b960302",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.2,
        "x": 0.242,
        "y": 0.438
      },
      "kind": "list",
      "text": "28% EMERGING MODALITIES\n7% MONOCLONAL ANTIBODIES\n11% PEPTIDES AND VACCINES\n6% SMALL MOLECULES",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7af1ad4c-aaac-4921-b4af-f47c5bf1b99f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.144,
        "w": 0.144,
        "x": 0.866,
        "y": 0.105
      },
      "kind": "metric",
      "text": "47%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59131283-6d73-43bc-8e02-5fe80cd8c2ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.08,
        "x": 0.732,
        "y": 0.137
      },
      "kind": "metric",
      "text": "23%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ae65207-2b6c-4d86-81f7-b1ef3fe8824b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "CAGR: 28%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-832d-736c-a658-4a540310d55c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.03,
        "y": 0.3
      },
      "kind": "source-note",
      "text": "Sources: EvaluatePharma; BCG analysis. Note: Analysis includes all assets with 1990-2030 FDA approval.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1b6c80f-8250-40ba-ad1f-a78f5032d271",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.55,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Better understanding of causal biology and novel modalities is fuelling growth of first-in-class products",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aaa1013a-4b6d-4c97-97c6-9667468df348",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "The rise of novel biology & modalities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee7ac79a-4664-4e68-bfc4-bd05183dce82",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 40,
      "from": 31,
      "beatId": "3ff6570d-a209-470b-8a44-57f3cea21f0e",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "The presentation outlines Syncona's platform, its compounding advantage, and its position to deliver returns to shareholders",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 45,
      "from": 39,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "913f54b4-72d9-47d7-b021-b19ce8ff34a5",
      "evidence": "The presentation highlights the global burden of disease and the need for innovative solutions",
      "position": 1,
      "objective": "What are the consequences of not addressing the unmet medical needs?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}